These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 1388757)
1. Formulation aspects on dermatological preparations and transdermal drug delivery systems. Junginger HE Acta Pharm Nord; 1992; 4(2):117. PubMed ID: 1388757 [No Abstract] [Full Text] [Related]
2. Importance of pharmaceutical formulation for dermatological preparations. Ross G Boll Chim Farm; 1981 Aug; 120(8):437-57. PubMed ID: 7317170 [No Abstract] [Full Text] [Related]
3. Multivesicular emulsion: a novel, controlled-release delivery system for topical dermatological agents. Bikowski J; Shroot B J Drugs Dermatol; 2006; 5(10):942-6. PubMed ID: 17373142 [TBL] [Abstract][Full Text] [Related]
4. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226 [TBL] [Abstract][Full Text] [Related]
5. [Drug storage and administration references. Drugs for cutaneous administration]. Kircher W Med Monatsschr Pharm; 1990 Jun; 13(6):187-90. PubMed ID: 2374514 [No Abstract] [Full Text] [Related]
6. [Topical therapy in dermatology: pharmaceutical forms, excipients and bases for magistral preparations]. Vennat B; Pouget MP; Pourrat A Ann Dermatol Venereol; 2000 Jan; 127(1):110-21. PubMed ID: 10717577 [No Abstract] [Full Text] [Related]
7. Transdermal drug delivery: clinical considerations for the obstetrician-gynecologist. Potts RO; Lobo RA Obstet Gynecol; 2005 May; 105(5 Pt 1):953-61. PubMed ID: 15863530 [TBL] [Abstract][Full Text] [Related]
8. Permeation enhancers compatible with transdermal drug delivery systems. Part I: selection and formulation considerations. Pfister WR; Hsieh DS Med Device Technol; 1990; 1(5):48-55. PubMed ID: 10171148 [TBL] [Abstract][Full Text] [Related]
9. Transdermal delivery of contraceptives. Friend DR Crit Rev Ther Drug Carrier Syst; 1990; 7(2):149-86. PubMed ID: 2272099 [TBL] [Abstract][Full Text] [Related]
12. Pilot study of topical delivery of methotrexate by electroporation. Wong TW; Zhao YL; Sen A; Hui SW Br J Dermatol; 2005 Mar; 152(3):524-30. PubMed ID: 15787822 [TBL] [Abstract][Full Text] [Related]
13. [Transdermal therapeutic systems for drug administration]. Hupfeld S; Gravem H Tidsskr Nor Laegeforen; 2009 Mar; 129(6):532-3. PubMed ID: 19282891 [TBL] [Abstract][Full Text] [Related]
14. Permeation enhancers compatible with transdermal drug delivery systems: part II: system design considerations. Pfister WR; Hsieh DS Med Device Technol; 1990; 1(6):28-33. PubMed ID: 10171149 [TBL] [Abstract][Full Text] [Related]